Elevations of nucleus accumbens dopamine and DOPAC levels during intravenous heroin self‐administration

Synapse - Tập 21 Số 2 - Trang 140-148 - 1995
Roy A. Wise1, Paola Leone, R Rivest, Kira Leeb
1Department of Psychology, Concordia University, Montreal, Quebec, Canada

Tóm tắt

AbstractExtracellular dopamine and DOPAC (3,4‐dihydroxyphenylacetic acid) levels in nucleus accumbens were sampled by microdialysis and quantified with high‐ performance liquid chromatography during intravenous heroin self‐administration sessions in rats. Dopamine levels in 10 and 20 min samples were elevated following the first injection of each session, reaching a plateau of elevation within the first two or three injections and falling back toward baseline only when drug access was terminated. Elevations were in the range of 150–300% when unit dosages of 0.05–0.2 mgkg were given. Increasing the work requirement from FR‐1 to FR‐10 did not appear to alter the degree of elevation of dopamine levels, and dopamine levels fell during extinction while lever‐pressing rates increased 20‐fold. While animals compensated for unit dose changes between 0.05 and 0.2 mg/kg/injection, adjusting their response rate such that the same hourly drug intake and the same asymptotic dopamine levels were maintained across these conditions, at 0.4 mg/kg/injection hourly drug intake and asymptotic dopamine levels were elevated beyond the levels sustained by the lower doses. These findings confirm that self‐administered doses of intravenous heroin are sufficient to activate the mesolimbic dopamine system and suggest that significant heroin “craving” can emerge when dopamine levels are still moderately elevated, long before the development of dopamine depletion associated with opiate withdrawal. © 1995 Wiley‐Liss, Inc.

Từ khóa


Tài liệu tham khảo

10.1016/0014-2999(91)90214-B

10.1037/h0083703

10.1016/0006-8993(83)91232-5

10.1016/0006-8993(87)91327-8

10.1016/0024-3205(81)90148-X

Bozarth M. A., 1986, Problems of Drug Dependence, 190

10.1016/0006-8993(83)91232-5

10.1016/0014-2999(76)90099-6

10.1016/0024-3205(78)90471-X

Bunney B. S., 1973, Dopaminergic neurons: Effect of antipsychotic drugs and amphetamine on single cell activity, J. Pharmacol. Exp. Ther., 185, 560

Carlezon W. A., 1994, Rats self‐administer phencyclidine (PCP) and MK‐801, but not nomifensine, directly into prefrontal cortex, Soc. Neurosci. Abstr., 20, 1628

Carlsson A., 1970, Amphetamines and Related Compounds, 289

10.1016/0149-7634(85)90022-3

10.1037/h0081662

10.1016/0197-0186(90)90112-7

10.1007/BF00405254

10.1523/JNEUROSCI.14-04-01978.1994

10.1016/0006-8993(93)90843-C

Devine D. P., 1993, Differential involvement of ventral tegmental mu, delta, and kappa opioid receptors in modulation of basal mesolimbic dopamine release: In vivo microdialysis studies, J. Pharmacol. Exp. Ther., 266, 1236

10.1111/j.1471-4159.1993.tb13615.x

10.1016/0006-8993(89)90723-3

Dworkin S. I., 1986, The reinforcing and rate effects of intracranial dopamine administration, NIDA Res. Monogr., 67, 242

10.1016/0091-3057(88)90138-4

10.1523/JNEUROSCI.08-01-00100.1988

10.1016/0149-7634(78)90052-0

10.1007/BF00428151

10.1016/0091-3057(84)90284-3

10.1126/science.6879176

Guerin G. F., 1984, Intracranial self‐administration of dopamine into the nucleus accumbens, Soc. Neurosci. Abstr., 10, 1072

10.1016/0006-8993(83)90913-7

10.1016/0006-2952(75)90152-5

Heikkila R. E., 1975, Amphetamine: Evaluation of d‐ and l‐isomers as releasing agents and uptake inhibitors for 3H‐dopamine and 3H‐norepinephrine slices of rat neostriatum and cerebral cortex, J. Pharmacol. Exp. Ther., 194, 47

10.1016/0361-9230(87)90047-5

10.1007/BF00429012

Hollerman J. R., 1990, The effects of dopamine‐depleting brain lesions on the electrophysiological activity of rat sub‐stantia nigra dopamine neurons., 533, 203

10.1016/0014-2999(89)90067-8

10.1016/0014-2999(92)90349-9

10.1016/0006-8993(87)90821-3

10.1523/JNEUROSCI.12-02-00483.1992

Kalivas P. W., 1983, Enkephalin action on the mesolimbic system: A dopamine‐dependent and a dopamine‐independent increase in locomotor activity, J. Pharmacol. Exper. Therap., 227, 229

10.1002/syn.890140109

10.1523/JNEUROSCI.09-04-01233.1989

Leeb K., 1994, The effect of intravenous self‐administration of of d‐and 1‐amphetamine on nucleus accumbens dopamine levels, Soc. Neurosci. Abstr., 20, 1622

10.1016/0091-3057(91)90210-S

10.1016/0306-4522(84)90048-4

10.1111/j.1471-4159.1989.tb07383.x

10.1016/0006-8993(79)90175-6

10.1016/0006-8993(82)90454-1

10.1002/syn.890090109

10.1007/BF00427441

10.1016/0091-3057(89)90291-8

10.1016/0091-3057(80)90460-8

10.1016/0006-8993(91)91724-F

10.1016/0091-3057(76)90113-1

10.1007/BF00433258

10.1016/0006-8993(91)90451-Z

10.1016/0006-8993(88)91560-0

10.1016/0014-2999(92)90706-A

Rossi N. A., 1976, Affective states associated with morphine injections., 4, 269

Shaham Y., 1994, Reinstatement of heroin self‐administration behavior by exposure to stress after prolonged extinction, Soc. Neurosci. Abstr., 20, 1230

10.1111/j.1749-6632.1992.tb25980.x

10.1007/BF02245289

10.1016/0006-3223(89)90052-8

Stinus L., 1986, Chronic treatment with five different neuroleptics elicits behavioral supersensitivity to opiate infusion into the nucleus accumbens., 21, 34

Stinus L., 1985, Chronic neuroleptic treatment and mesolimbic dopamine denervation induce behavioural supersensitivity to opiates., 85, 323

Swanson L. W., 1992, Brain Maps: Structure of the Rat Brain

10.1007/BF00431681

10.1016/S0091-3057(80)80039-6

Weeks J. R., 1962, Experimental morphine addiction: Method for automatic intravenous injections in unrestrained rats., 138, 143

10.1016/0028-3908(89)90112-3

West T. E. G., 1988, Nucleus accumbens opioids facilitate brain stimulation reward, Soc. Neurosci. Abstr., 14, 1102

10.1007/BF00169306

Sswise R. A., 1989, The Neuropharmacologi‐cal Basis of Reward, 377

10.1016/S0149-7634(89)80021-1

10.1111/j.1749-6632.1992.tb25967.x

Wise R. A., 1994, Elevations and phasic fluctuations in nucleus accumbens dopamine during IV cocaine self‐administration, Soc Neurosci. Abstr., 20, 1626

10.3109/10826086809042898

10.1126/science.1114313

10.1007/BF00496868

Zigmond M. J., 1990, Compensations after lesions of central dopa‐minergic neurons, Some clinical and basic implications., 13, 290

10.1016/0091-3057(85)90110-8

Thông tin
Thông tin xuất bản

Synapse

Tập 21 Số 2

140-148

Thông tin tác giả